Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
424studies shown
Showing 229-240 of 424
Other study type icon
RecruitingNCT05763966

Uppsala Psychosis Cohort

This summary needs review. Please check the official study record and contact the research team for details.

In Uppsala
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 40 Years
Countries
Sweden
Sponsor
Uppsala University
Condition
Schizophrenia
Drug study icon
RecruitingEUCTR 2021-000350-26

A double blind, randomized, placebo-controlled, adaptive 24-week Phase IIb trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia....

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

Multiple locations, including Kazanlik
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.
Countries
Bulgaria, Poland, Romania, ...
Sponsor
Oryzon Genomics, S.A.
Condition
Schizophrenia
Drug study icon
RecruitingEUCTR 2017-001170-42

An adaptive Phase II/III, Double-Blind, Randomized, Placebo-controlled, Two-Part, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase In...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

Multiple locations, including Gdańsk
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Poland
Sponsor
SyneuRx International (Taiwan) Corp
Condition
Schizophrenia
Drug study icon
RecruitingEUCTR 2021-001333-38

Cognitive effects of adjuntive Vortioxetine in early Schizophrenia

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Sevilla
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Spain
Sponsor
Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI)
Condition
Schizophrenia
Drug study icon
RecruitingEUCTR 2022-001582-12

Open, multicenter, randomized clinical trial to evaluate the efficacy and safety of aripiprazole vs paliperidone / risperidone using multi-omics data in patients with a first psychotic episode.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

Multiple locations, including Barcelona
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Spain
Sponsor
Consorcio Centro de Investigacion Biomedica en Red (CIBER)
Condition
Schizophrenia
Drug study icon
RecruitingNCT07105111

Effectiveness of valbenazine in adults with tardive dyskinesia

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Bryant
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, Depression, ...DrugOver 18 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia, Depression, ...
Drug study icon
RecruitingNCT04580134

CLOZAPINE Response in Biotype-1

This study is looking at whether clozapine can help people with Schizophrenia, schizoaffective disorder, or Bipolarity type I. Participants receive a study treatment and complete follow-up visits and assessments.

Multiple locations, including Hartford
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Schizophrenia, Bipolarity
Behavioral study icon
RecruitingNCT05805397

Effectiveness of Motivation Skills Training (MST)

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Columbia University
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.